Učitavanje...

Phase I study of intraventricular recombinant tissue plasminogen activator for treatment of posthaemorrhagic hydrocephalus.

AIM: Phase I study to evaluate intraventricular fibrinolytic treatment with recombinant tissue plasminogen activator (tPA) as a method of clearing blood from the cerebrospinal fluid, and thus preventing permanent hydrocephalus. METHODS: Twenty two preterm infants, aged 7 to 26 days, with progressive...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Whitelaw, A, Saliba, E, Fellman, V, Mowinckel, M C, Acolet, D, Marlow, N
Format: Artigo
Jezik:Inglês
Izdano: 1996
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1061145/
https://ncbi.nlm.nih.gov/pubmed/8795351
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!